Market capitalization | €117.80m |
Enterprise Value | €481.01m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 12.42 |
EV/Sales (TTM) EV/Sales | 0.66 |
P/S ratio (TTM) P/S ratio | 0.16 |
P/B ratio (TTM) P/B ratio | 0.59 |
Revenue growth (TTM) Revenue growth | 2.68% |
Revenue (TTM) Revenue | €733.27m |
As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.
1 Analyst has issued a forecast MediClin:
1 Analyst has issued a forecast MediClin:
Jun '24 |
+/-
%
|
||
Revenue | 733 733 |
3%
3%
|
|
Gross Profit | 50 50 |
24%
24%
|
|
EBITDA | 98 98 |
15%
15%
|
EBIT (Operating Income) EBIT | 13 13 |
45%
45%
|
Net Profit | -15 -15 |
226%
226%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
MediClin AG engages in the operation of hospitals, rehabilitation clinics, care homes and medical centers. It operates through the following segments: Post-Acute, Acute and Other Activities. The Post-Acute segment offers subsequent nursing and curative treatment services. The Acute segment focuses on neurology and neurological early rehabilitation, psychosomatic medicine, psychiatry, orthopedic and internal medicine. The Other Activities segment refers to nursing care and service business area including software support, controlling activities, quality assurance and other central services. The company was founded on September 12, 1996 and is headquartered in Offenburg, Germany.
Head office | Germany |
CEO | Joachim Ramming |
Employees | 9,613 |
Founded | 1996 |
Website | www.mediclin.de |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.